212 results
Page 4 of 11
10-K
EX-10.6
8t1v dzlf
12 Feb 18
Annual report
12:00am
10-K
EX-10.7
zkf61xf 0a
12 Feb 18
Annual report
12:00am
10-K
EX-10.8
j7kv1i u2
12 Feb 18
Annual report
12:00am
10-K
h5ezmj8tza4wr5c2zcv1
12 Feb 18
Annual report
12:00am
6-K
EX-99.1
xtg96z hily0jb52m
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
6-K
EX-4.2
lm6252a 5tz47ss0lbrg
25 Jul 16
Current report (foreign)
12:00am
424B5
h5bn9y ex2r
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
qnmnqu
13 Jul 16
Current report (foreign)
12:00am
424B5
fxxdgf1 k6ce8
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
co877h h71i6x3ex2
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
40qwyax
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
s98kt1fken5h hhik89
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
1g6ljdzq
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
4jhhea n7
6 Feb 14
Teva Reports Fourth Quarter and Full Year 2013 Results
12:00am